Summary
74 / 100 · Bulios Score
What speaks for it
- Revenue grew by 131% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $1.71B in the last fiscal year, 18% of its market value.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 2.6 CAD for 1 CAD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (CAD)
Diluted EPS (CAD)
- Analyst estimate
Revenue fell by 0.5% a year over 5 years. Over the last 3 years it grew by 131% a year. Earnings per share grew by 8.2% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 CAD of revenue goes
- Cost of sales 83 CAD
- Sales and administration 5.5 CAD
- Taxes and other 2.5 CAD
- Net profit 8.7 CAD
Net profit, industry median (Insurance - Diversified) 8.3 CAD
Out of every 100 CAD of revenue, 8.7 CAD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, safe- Yield
- 6.47%
- Paid out of profit
- 17%
- Raised in a row
- 1 year
You receive $0.77 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 4
- Hold 8
- Sell 2
No analyst has published a price target.
29% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Health Insurance 65%
- Life Insurance 24%
- Annuities 11%
By region
The company reports no revenue by region.
Health Insurance brings in 65% of revenue.
Segments in detail